OVIT (OncoVista Innovative Therapies) Retained Earnings: $-27.60 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Retained Earnings?

OncoVista Innovative Therapies OVIT Retained Earnings is $-27.60 Mil as of Sep. 2015.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. OncoVista Innovative Therapies's retained earnings for the quarter that ended in Sep. 2015 was $-27.60 Mil.

OncoVista Innovative Therapies's quarterly retained earnings declined from Mar. 2015 ($-26.18 Mil) to Jun. 2015 ($-27.28 Mil) and declined from Jun. 2015 ($-27.28 Mil) to Sep. 2015 ($-27.60 Mil).

OncoVista Innovative Therapies's annual retained earnings declined from Dec. 2012 ($-21.91 Mil) to Dec. 2013 ($-23.36 Mil) and declined from Dec. 2013 ($-23.36 Mil) to Dec. 2014 ($-25.90 Mil).

OncoVista Innovative Therapies  (OTCPK:OVIT) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

OncoVista Innovative Therapies Retained Earnings Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Retained Earnings Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.26 -20.28 -21.91 -23.36 -25.90

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.33 -25.90 -26.18 -27.28 -27.60

OncoVista Innovative Therapies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-27.60 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Retained Earnings of $-27.60 Mil as of Sep. 2015. Retained earnings is the amount of net income not issued to shareholders. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Retained Earnings too high?
OncoVista Innovative Therapies' current Retained Earnings is $-27.60 Mil.
How does OncoVista Innovative Therapies' Retained Earnings compare to RSPI and HSTC?
OncoVista Innovative Therapies' Retained Earnings of $-27.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Retained Earnings is $-27.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Retained Earnings of $-27.60 Mil. The current Retained Earnings is $-27.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Retained Earnings is $-27.60 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.